Coca-Cola remains resilient amid GLP-1 health trends and geopolitical risks, with proactive innovation and a diversified ...

Positive news from the laboratory was the wind beneath the wings of Novo Nordisk (NYSE: NVO) stock on Thursday. The ...

Younger generations, including my own, shouldn’t gloat, though: Cuts to Social Security and a halt to medical research could ...

Novo Nordisk stock climbs following the announcement of its plans to advance amycretin, a dual GLP-1/amylin agonist for ...

Investing.com -- The European Medicines Agency’s (EMA) safety committee, PRAC, said Friday that it has concluded that ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

The stock market is a place where people tend to panic when things go on sale. Instead, buy the dip on these four fabulous dividend winners.

Newly public Omada Health says it won't turn patient care over to AI as the tech consumes investor interest.

TheStreet. Even the Hamburglar didn’t see this one coming. Excessive weight has been a persistent problem in America, where ...

In news from the railway sector, shares of Kernex Microsystems jumped 5% after the company secured two contracts worth Rs 3.1 billion (bn) from Southern Railway in a joint venture. Kernex shares have ...

Investing.com -- Parvus Asset Management, a London-based activist hedge fund, is acquiring a stake in Danish pharmaceutical company Novo Nordisk (NYSE: NVO ), according to The Financial Times. The ...

Is there a hotter trend in healthcare than weight loss drugs? Probably not. Research from Morgan Stanley suggests that sales ...